Labor Induction Clinical Trial
Official title:
Shortening the Duration of Labor: Can We Remove Transcervical Foley Catheters Earlier
Verified date | November 2023 |
Source | Icahn School of Medicine at Mount Sinai |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The foley catheter (single lumen balloon) is one of the most cost effective, readily available methods for cervical ripening to begin an induction of labor. It is most commonly used in conjunction with oxytocin, a medication given to induce contractions. However, there is no clear timeline for when to remove the foley catheter or how long foley catheters can be safely kept in place. The study team's goal is to conduct a randomized controlled trial (RCT) in nulliparous and multiparous patients to determine the optimal length of time to retain foley catheters (single balloon) for induction of labor to achieve vaginal delivery while shortening the overall length of labor. Based on our power analysis, the study team plans to enroll a total of 356 patients (218 nulliparous patients and 138 multiparous patients) over the course of 18 months. Then the study team will randomize patients to one of the following two groups: foley catheter removal after 6 hours or foley catheter removal after 12 hours. All patients will receive simultaneous pitocin and a foley catheter, and the remainder of the induction course (i.e. rupture of membranes, etc.) will be left to the discretion of the obstetric provider. The primary outcome will be time of foley catheter insertion to delivery. Secondary outcomes will be rates of cesarean delivery and obstetric/neonatal outcomes.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 2022 |
Est. primary completion date | March 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Age 18 through 50 years old - Bishop score of 6 or less - Singleton pregnancies at 37 weeks or more - Absence of labor or rupture of membranes. Exclusion Criteria: - COVID positive patients - Previous history of cesarean delivery - Ruptured membranes (the institutional policy states women cannot have foley catheters placed if membranes are ruptured) - Documented labor on admission (will include only patients being induced) - Fetal distress on admission (e.g. indication for induction of labor being category 2 tracing as these patients may have increased risk of cesarean delivery) - Certain fetal anomalies (e.g. brain anomalies, abdominal wall or neural tube defects, fetal cardiac arrhythmias) - Contraindication to vaginal delivery |
Country | Name | City | State |
---|---|---|---|
United States | Mount Sinai West | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Icahn School of Medicine at Mount Sinai |
United States,
Bleicher I, Dikopoltsev E, Kadour-Ferro E, Sammour R, Gonen R, Sagi S, Eshel A, Nussam L, Vitner D. Double-Balloon Device for 6 Compared With 12 Hours for Cervical Ripening: A Randomized Controlled Trial. Obstet Gynecol. 2020 May;135(5):1153-1160. doi: 10.1097/AOG.0000000000003804. — View Citation
Lassey SC, Haber HR, Kanbergs A, Robinson JN, Little SE. Six versus twelve hours of single-balloon catheter placement with oxytocin administration for labor induction: a randomized controlled trial. Am J Obstet Gynecol. 2021 Jun;224(6):611.e1-611.e8. doi: 10.1016/j.ajog.2021.03.021. Epub 2021 Mar 23. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Length of Labor | Length of time from foley catheter insertion to delivery time in minutes at the time of infant delivery | Day 1, at time of infant delivery | |
Secondary | Number of Cesarean delivery | Number of delivery by Cesarean delivery | Day 1, at time of infant delivery | |
Secondary | Number of Maternal Intrapartum Fever | Number of participants with intrapartum fever | Day 1, at time of infant delivery | |
Secondary | Number of Participants that require Intrapartum antibiotic administration | Number of Participants that require Intrapartum antibiotic administration | Day 1, at time of infant delivery | |
Secondary | Number of Participants with Postpartum Hemorrhage | Number of participants who had postpartum hemorrhage | 6 Days Postpartum | |
Secondary | Number of NICU admission | The number of babies delivered by patients enrolled in the study who ended up admitted to the Neonatal Intensive Care Unity (NICU) for any amount of time | 6 Days Postpartum | |
Secondary | Number of neonatal participants with APGAR score <7 | Number of neonatal participants with 5 minute APGAR <7. APGAR score range is from 0-10, with the higher scores indicating better health outcome. | Day 1, 5 minutes of infant delivery | |
Secondary | Number of neonatal participants with hospital stay greater than 6 days | Number of neonatal participants with hospital stay greater than 6 days | 6 Days Postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00141895 -
A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Termination for Intrauterine Fetal Death
|
Phase 3 | |
Completed |
NCT03039036 -
Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction
|
N/A | |
Completed |
NCT05827731 -
Cervical Double Balloon Combined With Oxytocin
|
N/A | |
Recruiting |
NCT04035382 -
BMI-Associated Labor Induction: A Prospective Trial
|
N/A | |
Withdrawn |
NCT00771511 -
Cervical Capsaicin for Labor Induction and Pain Relief
|
Phase 4 | |
Recruiting |
NCT04075630 -
Observatory on Artificial Labour-induction Methods and Measuring Immediate Postpartum Maternal Satisfaction
|
||
Active, not recruiting |
NCT04573517 -
Early Amniotomy Following Transcervical Foley Balloon in the Induction of Labor
|
N/A | |
Recruiting |
NCT03016442 -
Dinoprostone Vaginal Insert Versus Double Balloon Catheter for Preinduction Cervical Ripening
|
Phase 2 | |
Not yet recruiting |
NCT00984347 -
Breast Stimulation Versus Pitocin for Induction of Labor
|
N/A | |
Completed |
NCT04596397 -
Oral Misoprostol for Outpatient Induction of Labor
|
N/A | |
Completed |
NCT03504670 -
Preterm Induction of Labor Timing of Amniotomy: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT00886860 -
The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol
|
Phase 4 | |
Completed |
NCT00504465 -
Combined Agent Randomized Trial of Induction of Labor
|
N/A | |
Completed |
NCT01402050 -
Foley Catheter Versus Cervidil for Induction of Labor at Term
|
N/A | |
Completed |
NCT01170819 -
Double Balloon Catheter Versus Dinoprostone Vaginal Insert for Cervical Ripening.
|
Phase 4 | |
Completed |
NCT00529295 -
Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term
|
Phase 3 | |
Completed |
NCT00442663 -
Trial of Foley Catheter With and Without Extra-Amniotic Saline Infusion for Labor Induction
|
N/A | |
Completed |
NCT00346840 -
Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour
|
Phase 2 | |
Withdrawn |
NCT03218735 -
Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus
|
N/A | |
Completed |
NCT02639429 -
Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial
|
Phase 4 |